APA-Zitierstil (7. Ausg.)

Mohelnikova-Duchonova, B., & Giese, N. (2017). SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival. Scientific reports, 7, . https://doi.org/10.1038/srep43812

Chicago-Zitierstil (17. Ausg.)

Mohelnikova-Duchonova, Beatrice, und Nathalia Giese. "SLC22A3 Polymorphisms Do Not Modify Pancreatic Cancer Risk, but May Influence Overall Patient Survival." Scientific Reports 7 (2017). https://doi.org/10.1038/srep43812.

MLA-Zitierstil (9. Ausg.)

Mohelnikova-Duchonova, Beatrice, und Nathalia Giese. "SLC22A3 Polymorphisms Do Not Modify Pancreatic Cancer Risk, but May Influence Overall Patient Survival." Scientific Reports, vol. 7, 2017, https://doi.org/10.1038/srep43812.